Sclerotherapy in the management of ovarian endometrioma: systematic review and meta-analysis

review OA: closed CC0 ⤵ 81 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This systematic review and meta-analysis examined sclerotherapy as a management option for ovarian endometriomas, assessing its efficacy and safety.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

ObjectiveTo evaluate the efficacy of sclerotherapy for ovarian endometrioma on the risk of recurrence, clinical symptoms, and reproductive function.DesignSystematic review and meta-analysis.SettingNot applicable.Patient(s)Patients who underwent sclerotherapy of ovarian endometrioma.Intervention(s)An electronic-based search with the use of Pubmed, Embase, Ovid Medline, Google Scholar, Clinicaltrials.gov, and the Cochrane Central Register of Controlled Trials.Main outcome measure(s)Recurrence rate, symptoms relief, fertility outcome, and adverse events.Result(s)Eighteen studies were included in our review. The overall recurrence rates of endometrioma after sclerotherapy ranged from 0 to 62.5%. The risk of recurrence was significantly higher in women who were treated by means of ethanol washing than by means of ethanol retention. The number of oocytes retrieved was higher after endometrioma sclerotherapy compared with laparoscopic cystectomy, but clinical pregnancy rates were similar. There was no difference in the number of oocytes retrieved and the clinical pregnancy rates between the sclerotherapy-treated group with and the untreated group.Conclusion(s)Sclerotherapy for ovarian endometrioma may be considered in symptomatic women who plan to conceive.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Endometriosis Endometriosis Infertility, Female Infertility, Female Pregnancy Outcome Sclerotherapy Adolescent Adult Endometriosis Female Humans Infertility, Female Middle Aged Ovarian Diseases Ovarian Diseases Ovarian Diseases Pregnancy Pregnancy Outcome Prevalence Recurrence

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (41)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-30T06:25:42.655704+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:20:25.745717+00:00
License: CC0 · commercial use OK